Clinical trial

BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT05393466

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2026-07-01Date precision: day

Registry last updated2025-10-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Carcinomaunresolved

Interventions

BPI-361175DRUG

Sponsors & collaborators

Xcovery Holdings, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05393466 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.